Trials / Conditions / High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
4 registered clinical trials studyying High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large NCT05600686 | Joseph Tuscano | Phase 2 |
| Suspended | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag NCT04799275 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Active Not Recruiting | Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Ly NCT04323956 | Mayo Clinic | Phase 1 |
| Completed | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagno NCT02199184 | M.D. Anderson Cancer Center | Phase 2 |